awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27002342-7C93829A-9F96-4E64-82C4-2C16591126DF
Q27002342-7C93829A-9F96-4E64-82C4-2C16591126DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27002342-7C93829A-9F96-4E64-82C4-2C16591126DF
Therapy decisions for the symptomatic patient with metastatic castration-resistant prostate cancer
P2860
Q27002342-7C93829A-9F96-4E64-82C4-2C16591126DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27002342-7C93829A-9F96-4E64-82C4-2C16591126DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
399a9504095d3906800ec81e94a7a247c6800ba2
P2860
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3